Germany · Delayed Price · Currency is EUR Imaging Biometrics Statistics
Total Valuation
FRA:5Y1 has a market cap or net worth of EUR 2.81 million. The enterprise value is 2.72 million.
| Market Cap | 2.81M |
| Enterprise Value | 2.72M |
Important Dates
The last earnings date was Thursday, November 20, 2025.
| Earnings Date | Nov 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 246.71M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +14.80% |
| Shares Change (QoQ) | +6.52% |
| Owned by Insiders (%) | 4.26% |
| Owned by Institutions (%) | n/a |
| Float | 170.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.44 |
| PB Ratio | 4.68 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -16.39 |
| EV / Sales | 3.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.57
| Current Ratio | 0.57 |
| Quick Ratio | 0.57 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -30.09% and return on invested capital (ROIC) is -18.81%.
| Return on Equity (ROE) | -30.09% |
| Return on Assets (ROA) | -8.63% |
| Return on Invested Capital (ROIC) | -18.81% |
| Return on Capital Employed (ROCE) | -27.73% |
| Revenue Per Employee | 116,636 |
| Profits Per Employee | -23,740 |
| Employee Count | 7 |
| Asset Turnover | 0.68 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.53% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +10.53% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 48.73 |
| Average Volume (20 Days) | 13 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:5Y1 had revenue of EUR 816,455 and -166,177 in losses. Loss per share was -0.00.
| Revenue | 816,455 |
| Gross Profit | 805,066 |
| Operating Income | -166,177 |
| Pretax Income | -166,177 |
| Net Income | -166,177 |
| EBITDA | -82,283 |
| EBIT | -166,177 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 84,414 in cash and n/a in debt, giving a net cash position of 84,414.
| Cash & Cash Equivalents | 84,414 |
| Total Debt | n/a |
| Net Cash | 84,414 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 599,192 |
| Book Value Per Share | 0.00 |
| Working Capital | -238,214 |
Cash Flow
| Operating Cash Flow | -158,676 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 98.61%, with operating and profit margins of -20.35% and -20.35%.
| Gross Margin | 98.61% |
| Operating Margin | -20.35% |
| Pretax Margin | -20.35% |
| Profit Margin | -20.35% |
| EBITDA Margin | -10.08% |
| EBIT Margin | -20.35% |
| FCF Margin | n/a |
Dividends & Yields
FRA:5Y1 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.80% |
| Shareholder Yield | -14.80% |
| Earnings Yield | -5.92% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:5Y1 has an Altman Z-Score of -29.46 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -29.46 |
| Piotroski F-Score | 2 |